市场调查报告书
商品编码
1173208
拇趾外翻矫正系统全球市场规模,份额和行业趋势分析报告,按产品(可穿戴设备,植入物和配件),最终用户(医院,门诊中心,专科中心)区域展望和预测2022-2028Global Bunion Correction Systems Market Size, Share & Industry Trends Analysis Report By Product (Wearables and Implants & Accessories), By End-Use (Hospitals, Ambulatory Centers, and Specialty Centers), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,拇外翻矫正系统的全球市场规模预计将达到 11 亿美元,预测期内復合年增长率为 7.1%。
美国踝关节骨科协会估计,大约三分之一的女性患有拇囊炎。 预计关节炎患者的增加将在预测期内对市场增长产生积极影响。 据说在类风湿性关节炎等炎症性关节炎的情况下更容易发生拇外翻。
患有类风湿性关节炎的人更容易出现足部问题。 根据 Vittori 的文章,脚部问题影响了全世界 90% 的类风湿性关节炎患者。 在类风湿性关节炎的情况下,据说拇囊炎更可能是由于身体错误地攻击了拇囊炎的内层。 此外,这两种疾病都有肿胀、关节活动不畅等症状,市场有望扩大。
COVID-19 影响分析
由于择期手术取消和寻求拇囊炎治疗的人数减少,COVID-19 疫情对市场产生了负面影响。 市场还受到医护人员短缺和政府为遏制病毒传播而实施的旅行限制的不利影响。 大多数医院和门诊康復中心的入住率较低,进一步阻碍了市场扩张。 许多医院正在缩减或推迟非紧急护理。 这不仅对医院,而且对他们所服务的患者都有财务和医疗影响。 由于 COVID-19,护士和其他医疗保健专业人员不得不轮班工作更长时间,工作时间甚至更长。
市场增长因素
提高渗透率
随着拇囊炎患者数量的增加,北美、亚太地区、欧洲和 LAMEA (MEA) 等地区对拇囊炎治疗设备的需求也在增加。 这与从青少年到成人的所有年龄组的拇囊炎发病率增加有关。
提高认识
拇外翻矫正器的知名度在提高,使用频率和手术次数也在增加。 拇囊炎也可能由其他疾病引起,例如关节炎、糖尿病和怀孕。 它们通常是由穿紧身鞋或过高的高跟鞋引起的。 今天,无论拇囊炎的原因是什么,都有许多治疗方法可以帮助您再次穿鞋感觉良好。 如果你想照顾好你的脚,拇囊炎需要仔细治疗。
市场抑制因素
患者对拇外翻的认识不足
拇囊炎的第一个征兆是在大脚趾关节的顶部或侧面出现一个小的骨质凸起。 拇囊炎一开始通常不会痛,所以很多人都会忽视它,直到它开始变得比不舒服或疼痛更烦人。
产品概览
拇外翻矫正系统市场按产品细分为可穿戴设备和植入配件。 到 2021 年,可穿戴设备将在所有产品类别中占据最高的收入份额。 拇囊炎发病率上升是推动市场增长的关键影响因素之一。 根据残疾人人口统计,大约36%的样本人口有这种情况。
结束使用 Outlook
按最终用户划分,市场分为医院、门诊中心和专科中心。 医院中矫正拇外翻的各种外科手术(如外切除术、截骨术和关节固定术)的可用性预计会增加接受这种病症治疗的患者数量。 此外,由于医院拥有优秀的医生,该行业的增长也有望加速。
区域展望
按地区分析北美、欧洲、亚太地区和 LAMEA 的拇外翻矫正系统市场。 2021年,北美以全球市场份额最高的优势主导了全球拇外翻矫正系统市场。 影响北美市场增长的关键因素包括该地区疾病的高发病率和矫正手术治疗中心的可及性。
The Global Bunion Correction Systems Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
Products for bunion correction assist in the treatment of foot deformity, which affects the metatarsophalangeal joint. One in three Americans has bunion or hallux valgus, which is a prevalent foot ailment in the adult population. The condition is most frequently brought on by wearing uncomfortable, narrow shoes for a long period, foot injuries, and genetic foot issues.
According to a study by NCBI ( National Center for Biotechnology Information), between 63% and 74% of the participants wore shoes that were either too short or too wide, increasing their chance of developing foot conditions such as bunions, calluses, and deformities. Due to weaker connective fibers and the usage of tight, heeled shoes, the ailment is more prevalent in older people, particularly women.
The American Orthopedic Foot and Ankle Society estimates that roughly one-third of women have bunions. During the forecast period, increasing arthritis prevalence is anticipated to favorably impact market growth. Bunions are more likely to develop in cases of inflammatory arthritis, such as rheumatoid arthritis.
There is a higher chance that people with rheumatoid arthritis will experience foot issues. According to a Vittori article, foot problems affect 90% of rheumatoid arthritis sufferers worldwide. The likelihood of developing a bunion increase as a result of the body incorrectly attacking the big toe linings in rheumatoid arthritis. Additionally, both illnesses' symptoms include swelling and problems with joint movement, which are predicted to boost market growth.
COVID-19 Impact Analysis
Owing to the cancellation of elective surgeries and the decline in individuals seeking bunion therapy, the COVID-19 pandemic had an adverse effect on the market. The market was also negatively impacted by the lack of healthcare workers and the government-imposed travel restrictions made to stop the virus's spread. The majority of hospitals and outpatient rehabilitation centers operated at decreased capacity, which further hampered market expansion. Numerous hospitals have reduced or delayed non-emergency care. This has both financial and medical repercussions for the hospitals as well as the patients they serve. Nurses and other healthcare professionals had to work longer shifts and even more days as a result of COVID-19.
Market Growth Factors
Growing Prevalence
The demand for these devices has increased throughout several regions, including North America, Asia Pacific, Europe, and LAMEA, as a result of the rise in the number of people with bunions (MEA). This can be linked to the rising incidence of this condition among people of all ages, including teenagers and adults.
Increasing Awareness
Patients are becoming more aware of bunion correction devices, and they are using them more frequently and in more surgical procedures. Bunions can also be brought on by other disorders like arthritis, diabetes, or even pregnancy. They are frequently brought on by wearing tight shoes or overly high heels. There are numerous treatments available today that will help you feel wonderful in your shoes again, no matter what the root of your bunions may be. If it comes to foot care, bunions need to be treated carefully.
Market Restraining Factors
Patient's Ignorance towards the Condition
A little bony protrusion on the top or side of your big toe joint is the first sign of the bunion toe disease (also known as a bunionette when it affects the pinky toe) (or on the pinky toe for bunionettes). Because bunions are typically not painful at first, so many individuals ignore it till the discomfort and pain start to get more bothersome.
Product Outlook
Based on product, the Bunion Correction system market is segmented into Wearables and Implants & Accessories. The wearables segment garnered the highest revenue share among all product categories in 2021. The increasing occurrence of bunions is one of the key influencing factors fuelling the market growth. According to statistics from Disabled Population, approximately 36% of the sample population had the condition.
End-Use Outlook
By end-use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. The number of patients receiving treatment for the issue at the hospitals is anticipated to increase as a result of factors like the accessibility of different surgical alternatives including Exostectomy, Osteotomy, and Arthrodesis for bunion correction. Additionally, it is anticipated that the hospitals' access to qualified doctors will accelerate category growth.
Regional Outlook
Region-wise, the Bunion Correction Systems Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, North America dominated the global Bunion Correction Systems market with the highest market share worldwide. Some of the major factors that influenced the market growth in the North America market include the higher incidence of the condition there as well as the accessibility of treatment centers for corrective operations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
Strategies Deployed in Bunion Correction Systems Market
Jul-2022: Acumed acquired Exosmed, a medical device company specialized in providing innovative solutions to orthopedic surgeons. The acquisition enables Acumed to better serve minimally invasive surgical device customers globally.
Mar-2022: Orthofix received the approval from U.S. Food and Drug Administration 510(k) for TrueLok EVO Ring Fixation System. TrueLok EVO Ring Fixation System is designed for deformity correction procedures and complex limb reconstruction. This is the only circular fixator that has struts and radiolucent rings for clear radiographic visualization.
Feb-2022: Stryker acquired Vocera Communications, a provider of the leading platform for clinical workflow and communications. The acquisition enriched Stryker's Medical division through adding an innovative and complementary portfolio. The addition broadened the company's Advance Digital Healthcare offerings and advanced its focus on preventing unfavorable events during the continuum of care.
Feb-2022: DePuy Synthes took over CrossRoads Extremity Systems, a medical device company engaged in providing a wide range of procedure-focused, sterile-packed implants and instrumentation systems. This acquisition adds CrossRoads' products to DePuy's product portfolio reinforcing DePuy's portfolio of foot and ankle procedures.
Dec-2021: DePuy Synthes, a subsidiary of Johnson & Johnson acquired OrthoSpin, Ltd., a medical equipment manufacturing firm specializing in developing robotic treatment systems. With this acquisition, OrthoSpin helped DePuy in bringing transformative Medtech advancements to the industry through utilizing automated technology, which addresses a range of orthopaedic challenges.
Sep-2021: Stryker completed the acquisition of Gauss Surgical, a medical device company that developed an artificial intelligence-enabled platform, Triton. This platform was developed for real-time monitoring of blood loss at the time of surgery. Following this acquisition, Stryer aimed to utilize this platform for improving outcomes and safety for their patients and caregivers.
Jan-2021: Stryker took over OrthoSensor, a company focused on the digital evolution of sensor technology and musculoskeletal care for total joint replacement. Through this acquisition, the latter company empowered the former company's surgeons with exhaustive data-driven solutions. Additionally, Orhtosensor's portfolio reinforced Stryker's digital ecosystem foundation.
Dec-2020: Zimmer Biomet announced the acquisition of A&E Medical Corporation, a manufacturer of medical devices. The acquisition enabled Zimmer to deliver a comprehensive portfolio of sternal closure products, comprising rigid fixation. Rigid Fixation has the ability to address a range of unfulfilled surgical and patient requirements.
Mar-2020: Orthofix announced the acquisition of FITBONE, a brand of Wittenstein SE. FITBONE is an intramedullary lengthening system for limb lengthening of the tibia and femur. With this acquisition, FITBONE enhanced Orthofix's limb reconstruction portfolio allowing physicians to better serve the needs of patients that require internal and external fixation procedures.
Market Segments covered in the Report:
By Product
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures